Biologics and Biosimilars Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Biologics and Biosimilars in global, including the following market information:
Global Biologics and Biosimilars Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Biologics and Biosimilars Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Biologics and Biosimilars companies in 2020 (%)
The global Biologics and Biosimilars market was valued at 187660 million in 2020 and is projected to reach US$ 226910 million by 2027, at a CAGR of 4.9% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologics and Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologics and Biosimilars Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, By Type, 2020 (%)
Global Biologics and Biosimilars Market Segment Percentages, By Application, 2020 (%)
Global Biologics and Biosimilars Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Key companies Biologics and Biosimilars revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Biologics and Biosimilars revenues share in global market, 2020 (%)
Key companies Biologics and Biosimilars sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Biologics and Biosimilars sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Biologics and Biosimilars Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Biologics and Biosimilars Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Biologics and Biosimilars companies in 2020 (%)
The global Biologics and Biosimilars market was valued at 187660 million in 2020 and is projected to reach US$ 226910 million by 2027, at a CAGR of 4.9% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologics and Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologics and Biosimilars Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, By Type, 2020 (%)
- Monoclonal Antibodies
- Interferon
- Erythropoietin
- Insulin
- Vaccines
- Others
Global Biologics and Biosimilars Market Segment Percentages, By Application, 2020 (%)
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Others
Global Biologics and Biosimilars Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Biologics and Biosimilars revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Biologics and Biosimilars revenues share in global market, 2020 (%)
Key companies Biologics and Biosimilars sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Biologics and Biosimilars sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- 3sbio
- Changchun High Tech
- CP Guojian
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
- United Laboratories
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Biologics and Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologics and Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BIOLOGICS AND BIOSIMILARS OVERALL MARKET SIZE
2.1 Global Biologics and Biosimilars Market Size: 2021 VS 2027
2.2 Global Biologics and Biosimilars Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Biologics and Biosimilars Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Biologics and Biosimilars Players in Global Market
3.2 Top Global Biologics and Biosimilars Companies Ranked by Revenue
3.3 Global Biologics and Biosimilars Revenue by Companies
3.4 Global Biologics and Biosimilars Sales by Companies
3.5 Global Biologics and Biosimilars Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Biologics and Biosimilars Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Biologics and Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologics and Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Biologics and Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologics and Biosimilars Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Biologics and Biosimilars Market Size Markets, 2021 & 2027
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Erythropoietin
4.1.5 Insulin
4.1.6 Vaccines
4.1.7 Others
4.2 By Type - Global Biologics and Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biologics and Biosimilars Revenue, 2016-2021
4.2.2 By Type - Global Biologics and Biosimilars Revenue, 2022-2027
4.2.3 By Type - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
4.3 By Type - Global Biologics and Biosimilars Sales & Forecasts
4.3.1 By Type - Global Biologics and Biosimilars Sales, 2016-2021
4.3.2 By Type - Global Biologics and Biosimilars Sales, 2022-2027
4.3.3 By Type - Global Biologics and Biosimilars Sales Market Share, 2016-2027
4.4 By Type - Global Biologics and Biosimilars Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Biologics and Biosimilars Market Size, 2021 & 2027
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Others
5.2 By Application - Global Biologics and Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biologics and Biosimilars Revenue, 2016-2021
5.2.2 By Application - Global Biologics and Biosimilars Revenue, 2022-2027
5.2.3 By Application - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
5.3 By Application - Global Biologics and Biosimilars Sales & Forecasts
5.3.1 By Application - Global Biologics and Biosimilars Sales, 2016-2021
5.3.2 By Application - Global Biologics and Biosimilars Sales, 2022-2027
5.3.3 By Application - Global Biologics and Biosimilars Sales Market Share, 2016-2027
5.4 By Application - Global Biologics and Biosimilars Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Biologics and Biosimilars Market Size, 2021 & 2027
6.2 By Region - Global Biologics and Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biologics and Biosimilars Revenue, 2016-2021
6.2.2 By Region - Global Biologics and Biosimilars Revenue, 2022-2027
6.2.3 By Region - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
6.3 By Region - Global Biologics and Biosimilars Sales & Forecasts
6.3.1 By Region - Global Biologics and Biosimilars Sales, 2016-2021
6.3.2 By Region - Global Biologics and Biosimilars Sales, 2022-2027
6.3.3 By Region - Global Biologics and Biosimilars Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Biologics and Biosimilars Revenue, 2016-2027
6.4.2 By Country - North America Biologics and Biosimilars Sales, 2016-2027
6.4.3 US Biologics and Biosimilars Market Size, 2016-2027
6.4.4 Canada Biologics and Biosimilars Market Size, 2016-2027
6.4.5 Mexico Biologics and Biosimilars Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Biologics and Biosimilars Revenue, 2016-2027
6.5.2 By Country - Europe Biologics and Biosimilars Sales, 2016-2027
6.5.3 Germany Biologics and Biosimilars Market Size, 2016-2027
6.5.4 France Biologics and Biosimilars Market Size, 2016-2027
6.5.5 U.K. Biologics and Biosimilars Market Size, 2016-2027
6.5.6 Italy Biologics and Biosimilars Market Size, 2016-2027
6.5.7 Russia Biologics and Biosimilars Market Size, 2016-2027
6.5.8 Nordic Countries Biologics and Biosimilars Market Size, 2016-2027
6.5.9 Benelux Biologics and Biosimilars Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Biologics and Biosimilars Revenue, 2016-2027
6.6.2 By Region - Asia Biologics and Biosimilars Sales, 2016-2027
6.6.3 China Biologics and Biosimilars Market Size, 2016-2027
6.6.4 Japan Biologics and Biosimilars Market Size, 2016-2027
6.6.5 South Korea Biologics and Biosimilars Market Size, 2016-2027
6.6.6 Southeast Asia Biologics and Biosimilars Market Size, 2016-2027
6.6.7 India Biologics and Biosimilars Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Biologics and Biosimilars Revenue, 2016-2027
6.7.2 By Country - South America Biologics and Biosimilars Sales, 2016-2027
6.7.3 Brazil Biologics and Biosimilars Market Size, 2016-2027
6.7.4 Argentina Biologics and Biosimilars Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biologics and Biosimilars Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Biologics and Biosimilars Sales, 2016-2027
6.8.3 Turkey Biologics and Biosimilars Market Size, 2016-2027
6.8.4 Israel Biologics and Biosimilars Market Size, 2016-2027
6.8.5 Saudi Arabia Biologics and Biosimilars Market Size, 2016-2027
6.8.6 UAE Biologics and Biosimilars Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologics and Biosimilars Major Product Offerings
7.1.4 Roche Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biologics and Biosimilars Major Product Offerings
7.2.4 Amgen Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.2.5 Amgen Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biologics and Biosimilars Major Product Offerings
7.3.4 AbbVie Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.3.5 AbbVie Key News
7.4 Sanofi-Aventis
7.4.1 Sanofi-Aventis Corporate Summary
7.4.2 Sanofi-Aventis Business Overview
7.4.3 Sanofi-Aventis Biologics and Biosimilars Major Product Offerings
7.4.4 Sanofi-Aventis Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.4.5 Sanofi-Aventis Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biologics and Biosimilars Major Product Offerings
7.5.4 Johnson & Johnson Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biologics and Biosimilars Major Product Offerings
7.6.4 Pfizer Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.6.5 Pfizer Key News
7.7 Novo Nordisk
7.7.1 Novo Nordisk Corporate Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Biologics and Biosimilars Major Product Offerings
7.4.4 Novo Nordisk Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.7.5 Novo Nordisk Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Biologics and Biosimilars Major Product Offerings
7.8.4 Eli Lilly Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.8.5 Eli Lilly Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Biologics and Biosimilars Major Product Offerings
7.9.4 Novartis Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.9.5 Novartis Key News
7.10 Merck
7.10.1 Merck Corporate Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biologics and Biosimilars Major Product Offerings
7.10.4 Merck Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.10.5 Merck Key News
7.11 3sbio
7.11.1 3sbio Corporate Summary
7.11.2 3sbio Biologics and Biosimilars Business Overview
7.11.3 3sbio Biologics and Biosimilars Major Product Offerings
7.11.4 3sbio Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.11.5 3sbio Key News
7.12 Changchun High Tech
7.12.1 Changchun High Tech Corporate Summary
7.12.2 Changchun High Tech Biologics and Biosimilars Business Overview
7.12.3 Changchun High Tech Biologics and Biosimilars Major Product Offerings
7.12.4 Changchun High Tech Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.12.5 Changchun High Tech Key News
7.13 CP Guojian
7.13.1 CP Guojian Corporate Summary
7.13.2 CP Guojian Biologics and Biosimilars Business Overview
7.13.3 CP Guojian Biologics and Biosimilars Major Product Offerings
7.13.4 CP Guojian Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.13.5 CP Guojian Key News
7.14 Biotech
7.14.1 Biotech Corporate Summary
7.14.2 Biotech Business Overview
7.14.3 Biotech Biologics and Biosimilars Major Product Offerings
7.14.4 Biotech Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.14.5 Biotech Key News
7.15 Gelgen
7.15.1 Gelgen Corporate Summary
7.15.2 Gelgen Business Overview
7.15.3 Gelgen Biologics and Biosimilars Major Product Offerings
7.15.4 Gelgen Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.15.5 Gelgen Key News
7.16 Innovent
7.16.1 Innovent Corporate Summary
7.16.2 Innovent Business Overview
7.16.3 Innovent Biologics and Biosimilars Major Product Offerings
7.16.4 Innovent Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.16.5 Innovent Key News
7.17 Dong Bao
7.17.1 Dong Bao Corporate Summary
7.17.2 Dong Bao Business Overview
7.17.3 Dong Bao Biologics and Biosimilars Major Product Offerings
7.17.4 Dong Bao Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.17.5 Dong Bao Key News
7.18 Ganlee
7.18.1 Ganlee Corporate Summary
7.18.2 Ganlee Business Overview
7.18.3 Ganlee Biologics and Biosimilars Major Product Offerings
7.18.4 Ganlee Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.18.5 Ganlee Key News
7.19 United Laboratories
7.19.1 United Laboratories Corporate Summary
7.19.2 United Laboratories Business Overview
7.19.3 United Laboratories Biologics and Biosimilars Major Product Offerings
7.19.4 United Laboratories Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.19.5 United Laboratories Key News
8 GLOBAL BIOLOGICS AND BIOSIMILARS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Biologics and Biosimilars Production Capacity, 2016-2027
8.2 Biologics and Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologics and Biosimilars Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BIOLOGICS AND BIOSIMILARS SUPPLY CHAIN ANALYSIS
10.1 Biologics and Biosimilars Industry Value Chain
10.2 Biologics and Biosimilars Upstream Market
10.3 Biologics and Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologics and Biosimilars Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Biologics and Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologics and Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BIOLOGICS AND BIOSIMILARS OVERALL MARKET SIZE
2.1 Global Biologics and Biosimilars Market Size: 2021 VS 2027
2.2 Global Biologics and Biosimilars Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Biologics and Biosimilars Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Biologics and Biosimilars Players in Global Market
3.2 Top Global Biologics and Biosimilars Companies Ranked by Revenue
3.3 Global Biologics and Biosimilars Revenue by Companies
3.4 Global Biologics and Biosimilars Sales by Companies
3.5 Global Biologics and Biosimilars Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Biologics and Biosimilars Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Biologics and Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologics and Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Biologics and Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologics and Biosimilars Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Biologics and Biosimilars Market Size Markets, 2021 & 2027
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Erythropoietin
4.1.5 Insulin
4.1.6 Vaccines
4.1.7 Others
4.2 By Type - Global Biologics and Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biologics and Biosimilars Revenue, 2016-2021
4.2.2 By Type - Global Biologics and Biosimilars Revenue, 2022-2027
4.2.3 By Type - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
4.3 By Type - Global Biologics and Biosimilars Sales & Forecasts
4.3.1 By Type - Global Biologics and Biosimilars Sales, 2016-2021
4.3.2 By Type - Global Biologics and Biosimilars Sales, 2022-2027
4.3.3 By Type - Global Biologics and Biosimilars Sales Market Share, 2016-2027
4.4 By Type - Global Biologics and Biosimilars Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Biologics and Biosimilars Market Size, 2021 & 2027
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Others
5.2 By Application - Global Biologics and Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biologics and Biosimilars Revenue, 2016-2021
5.2.2 By Application - Global Biologics and Biosimilars Revenue, 2022-2027
5.2.3 By Application - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
5.3 By Application - Global Biologics and Biosimilars Sales & Forecasts
5.3.1 By Application - Global Biologics and Biosimilars Sales, 2016-2021
5.3.2 By Application - Global Biologics and Biosimilars Sales, 2022-2027
5.3.3 By Application - Global Biologics and Biosimilars Sales Market Share, 2016-2027
5.4 By Application - Global Biologics and Biosimilars Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Biologics and Biosimilars Market Size, 2021 & 2027
6.2 By Region - Global Biologics and Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biologics and Biosimilars Revenue, 2016-2021
6.2.2 By Region - Global Biologics and Biosimilars Revenue, 2022-2027
6.2.3 By Region - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
6.3 By Region - Global Biologics and Biosimilars Sales & Forecasts
6.3.1 By Region - Global Biologics and Biosimilars Sales, 2016-2021
6.3.2 By Region - Global Biologics and Biosimilars Sales, 2022-2027
6.3.3 By Region - Global Biologics and Biosimilars Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Biologics and Biosimilars Revenue, 2016-2027
6.4.2 By Country - North America Biologics and Biosimilars Sales, 2016-2027
6.4.3 US Biologics and Biosimilars Market Size, 2016-2027
6.4.4 Canada Biologics and Biosimilars Market Size, 2016-2027
6.4.5 Mexico Biologics and Biosimilars Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Biologics and Biosimilars Revenue, 2016-2027
6.5.2 By Country - Europe Biologics and Biosimilars Sales, 2016-2027
6.5.3 Germany Biologics and Biosimilars Market Size, 2016-2027
6.5.4 France Biologics and Biosimilars Market Size, 2016-2027
6.5.5 U.K. Biologics and Biosimilars Market Size, 2016-2027
6.5.6 Italy Biologics and Biosimilars Market Size, 2016-2027
6.5.7 Russia Biologics and Biosimilars Market Size, 2016-2027
6.5.8 Nordic Countries Biologics and Biosimilars Market Size, 2016-2027
6.5.9 Benelux Biologics and Biosimilars Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Biologics and Biosimilars Revenue, 2016-2027
6.6.2 By Region - Asia Biologics and Biosimilars Sales, 2016-2027
6.6.3 China Biologics and Biosimilars Market Size, 2016-2027
6.6.4 Japan Biologics and Biosimilars Market Size, 2016-2027
6.6.5 South Korea Biologics and Biosimilars Market Size, 2016-2027
6.6.6 Southeast Asia Biologics and Biosimilars Market Size, 2016-2027
6.6.7 India Biologics and Biosimilars Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Biologics and Biosimilars Revenue, 2016-2027
6.7.2 By Country - South America Biologics and Biosimilars Sales, 2016-2027
6.7.3 Brazil Biologics and Biosimilars Market Size, 2016-2027
6.7.4 Argentina Biologics and Biosimilars Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biologics and Biosimilars Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Biologics and Biosimilars Sales, 2016-2027
6.8.3 Turkey Biologics and Biosimilars Market Size, 2016-2027
6.8.4 Israel Biologics and Biosimilars Market Size, 2016-2027
6.8.5 Saudi Arabia Biologics and Biosimilars Market Size, 2016-2027
6.8.6 UAE Biologics and Biosimilars Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologics and Biosimilars Major Product Offerings
7.1.4 Roche Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biologics and Biosimilars Major Product Offerings
7.2.4 Amgen Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.2.5 Amgen Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biologics and Biosimilars Major Product Offerings
7.3.4 AbbVie Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.3.5 AbbVie Key News
7.4 Sanofi-Aventis
7.4.1 Sanofi-Aventis Corporate Summary
7.4.2 Sanofi-Aventis Business Overview
7.4.3 Sanofi-Aventis Biologics and Biosimilars Major Product Offerings
7.4.4 Sanofi-Aventis Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.4.5 Sanofi-Aventis Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biologics and Biosimilars Major Product Offerings
7.5.4 Johnson & Johnson Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biologics and Biosimilars Major Product Offerings
7.6.4 Pfizer Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.6.5 Pfizer Key News
7.7 Novo Nordisk
7.7.1 Novo Nordisk Corporate Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Biologics and Biosimilars Major Product Offerings
7.4.4 Novo Nordisk Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.7.5 Novo Nordisk Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Biologics and Biosimilars Major Product Offerings
7.8.4 Eli Lilly Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.8.5 Eli Lilly Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Biologics and Biosimilars Major Product Offerings
7.9.4 Novartis Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.9.5 Novartis Key News
7.10 Merck
7.10.1 Merck Corporate Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biologics and Biosimilars Major Product Offerings
7.10.4 Merck Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.10.5 Merck Key News
7.11 3sbio
7.11.1 3sbio Corporate Summary
7.11.2 3sbio Biologics and Biosimilars Business Overview
7.11.3 3sbio Biologics and Biosimilars Major Product Offerings
7.11.4 3sbio Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.11.5 3sbio Key News
7.12 Changchun High Tech
7.12.1 Changchun High Tech Corporate Summary
7.12.2 Changchun High Tech Biologics and Biosimilars Business Overview
7.12.3 Changchun High Tech Biologics and Biosimilars Major Product Offerings
7.12.4 Changchun High Tech Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.12.5 Changchun High Tech Key News
7.13 CP Guojian
7.13.1 CP Guojian Corporate Summary
7.13.2 CP Guojian Biologics and Biosimilars Business Overview
7.13.3 CP Guojian Biologics and Biosimilars Major Product Offerings
7.13.4 CP Guojian Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.13.5 CP Guojian Key News
7.14 Biotech
7.14.1 Biotech Corporate Summary
7.14.2 Biotech Business Overview
7.14.3 Biotech Biologics and Biosimilars Major Product Offerings
7.14.4 Biotech Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.14.5 Biotech Key News
7.15 Gelgen
7.15.1 Gelgen Corporate Summary
7.15.2 Gelgen Business Overview
7.15.3 Gelgen Biologics and Biosimilars Major Product Offerings
7.15.4 Gelgen Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.15.5 Gelgen Key News
7.16 Innovent
7.16.1 Innovent Corporate Summary
7.16.2 Innovent Business Overview
7.16.3 Innovent Biologics and Biosimilars Major Product Offerings
7.16.4 Innovent Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.16.5 Innovent Key News
7.17 Dong Bao
7.17.1 Dong Bao Corporate Summary
7.17.2 Dong Bao Business Overview
7.17.3 Dong Bao Biologics and Biosimilars Major Product Offerings
7.17.4 Dong Bao Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.17.5 Dong Bao Key News
7.18 Ganlee
7.18.1 Ganlee Corporate Summary
7.18.2 Ganlee Business Overview
7.18.3 Ganlee Biologics and Biosimilars Major Product Offerings
7.18.4 Ganlee Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.18.5 Ganlee Key News
7.19 United Laboratories
7.19.1 United Laboratories Corporate Summary
7.19.2 United Laboratories Business Overview
7.19.3 United Laboratories Biologics and Biosimilars Major Product Offerings
7.19.4 United Laboratories Biologics and Biosimilars Sales and Revenue in Global (2016-2021)
7.19.5 United Laboratories Key News
8 GLOBAL BIOLOGICS AND BIOSIMILARS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Biologics and Biosimilars Production Capacity, 2016-2027
8.2 Biologics and Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologics and Biosimilars Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BIOLOGICS AND BIOSIMILARS SUPPLY CHAIN ANALYSIS
10.1 Biologics and Biosimilars Industry Value Chain
10.2 Biologics and Biosimilars Upstream Market
10.3 Biologics and Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologics and Biosimilars Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Biologics and Biosimilars in Global Market
Table 2. Top Biologics and Biosimilars Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Biologics and Biosimilars Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Biologics and Biosimilars Revenue Share by Companies, 2016-2021
Table 5. Global Biologics and Biosimilars Sales by Companies, (K Units), 2016-2021
Table 6. Global Biologics and Biosimilars Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Biologics and Biosimilars Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Biologics and Biosimilars Product Type
Table 9. List of Global Tier 1 Biologics and Biosimilars Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologics and Biosimilars Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Biologics and Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Biologics and Biosimilars Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Biologics and Biosimilars Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Biologics and Biosimilars Sales (K Units), 2016-2021
Table 15. By Type - Global Biologics and Biosimilars Sales (K Units), 2022-2027
Table 16. By Application – Global Biologics and Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Biologics and Biosimilars Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Biologics and Biosimilars Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Biologics and Biosimilars Sales (K Units), 2016-2021
Table 20. By Application - Global Biologics and Biosimilars Sales (K Units), 2022-2027
Table 21. By Region – Global Biologics and Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Biologics and Biosimilars Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Biologics and Biosimilars Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Biologics and Biosimilars Sales (K Units), 2016-2021
Table 25. By Region - Global Biologics and Biosimilars Sales (K Units), 2022-2027
Table 26. By Country - North America Biologics and Biosimilars Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Biologics and Biosimilars Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Biologics and Biosimilars Sales, (K Units), 2016-2021
Table 29. By Country - North America Biologics and Biosimilars Sales, (K Units), 2022-2027
Table 30. By Country - Europe Biologics and Biosimilars Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Biologics and Biosimilars Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Biologics and Biosimilars Sales, (K Units), 2016-2021
Table 33. By Country - Europe Biologics and Biosimilars Sales, (K Units), 2022-2027
Table 34. By Region - Asia Biologics and Biosimilars Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Biologics and Biosimilars Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Biologics and Biosimilars Sales, (K Units), 2016-2021
Table 37. By Region - Asia Biologics and Biosimilars Sales, (K Units), 2022-2027
Table 38. By Country - South America Biologics and Biosimilars Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Biologics and Biosimilars Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Biologics and Biosimilars Sales, (K Units), 2016-2021
Table 41. By Country - South America Biologics and Biosimilars Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Biologics and Biosimilars Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Biologics and Biosimilars Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Biologics and Biosimilars Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Biologics and Biosimilars Sales, (K Units), 2022-2027
Table 46. Roche Corporate Summary
Table 47. Roche Biologics and Biosimilars Product Offerings
Table 48. Roche Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Amgen Corporate Summary
Table 50. Amgen Biologics and Biosimilars Product Offerings
Table 51. Amgen Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. AbbVie Corporate Summary
Table 53. AbbVie Biologics and Biosimilars Product Offerings
Table 54. AbbVie Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Sanofi-Aventis Corporate Summary
Table 56. Sanofi-Aventis Biologics and Biosimilars Product Offerings
Table 57. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Johnson & Johnson Corporate Summary
Table 59. Johnson & Johnson Biologics and Biosimilars Product Offerings
Table 60. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Biologics and Biosimilars Product Offerings
Table 63. Pfizer Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Novo Nordisk Corporate Summary
Table 65. Novo Nordisk Biologics and Biosimilars Product Offerings
Table 66. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Eli Lilly Corporate Summary
Table 68. Eli Lilly Biologics and Biosimilars Product Offerings
Table 69. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Novartis Corporate Summary
Table 71. Novartis Biologics and Biosimilars Product Offerings
Table 72. Novartis Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Merck Corporate Summary
Table 74. Merck Biologics and Biosimilars Product Offerings
Table 75. Merck Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. 3sbio Corporate Summary
Table 77. 3sbio Biologics and Biosimilars Product Offerings
Table 78. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. Changchun High Tech Corporate Summary
Table 80. Changchun High Tech Biologics and Biosimilars Product Offerings
Table 81. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 82. CP Guojian Corporate Summary
Table 83. CP Guojian Biologics and Biosimilars Product Offerings
Table 84. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 85. Biotech Corporate Summary
Table 86. Biotech Biologics and Biosimilars Product Offerings
Table 87. Biotech Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 88. Gelgen Corporate Summary
Table 89. Gelgen Biologics and Biosimilars Product Offerings
Table 90. Gelgen Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 91. Innovent Corporate Summary
Table 92. Innovent Biologics and Biosimilars Product Offerings
Table 93. Innovent Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 94. Dong Bao Corporate Summary
Table 95. Dong Bao Biologics and Biosimilars Product Offerings
Table 96. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 97. Ganlee Corporate Summary
Table 98. Ganlee Biologics and Biosimilars Product Offerings
Table 99. Ganlee Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 100. United Laboratories Corporate Summary
Table 101. United Laboratories Biologics and Biosimilars Product Offerings
Table 102. United Laboratories Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 103. Biologics and Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 104. Global Biologics and Biosimilars Capacity Market Share of Key Manufacturers, 2019-2021
Table 105. Global Biologics and Biosimilars Production by Region, 2016-2021 (K Units)
Table 106. Global Biologics and Biosimilars Production by Region, 2022-2027 (K Units)
Table 107. Biologics and Biosimilars Market Opportunities & Trends in Global Market
Table 108. Biologics and Biosimilars Market Drivers in Global Market
Table 109. Biologics and Biosimilars Market Restraints in Global Market
Table 110. Biologics and Biosimilars Raw Materials
Table 111. Biologics and Biosimilars Raw Materials Suppliers in Global Market
Table 112. Typical Biologics and Biosimilars Downstream
Table 113. Biologics and Biosimilars Downstream Clients in Global Market
Table 114. Biologics and Biosimilars Distributors and Sales Agents in Global Market
Table 1. Key Players of Biologics and Biosimilars in Global Market
Table 2. Top Biologics and Biosimilars Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Biologics and Biosimilars Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Biologics and Biosimilars Revenue Share by Companies, 2016-2021
Table 5. Global Biologics and Biosimilars Sales by Companies, (K Units), 2016-2021
Table 6. Global Biologics and Biosimilars Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Biologics and Biosimilars Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Biologics and Biosimilars Product Type
Table 9. List of Global Tier 1 Biologics and Biosimilars Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologics and Biosimilars Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Biologics and Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Biologics and Biosimilars Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Biologics and Biosimilars Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Biologics and Biosimilars Sales (K Units), 2016-2021
Table 15. By Type - Global Biologics and Biosimilars Sales (K Units), 2022-2027
Table 16. By Application – Global Biologics and Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Biologics and Biosimilars Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Biologics and Biosimilars Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Biologics and Biosimilars Sales (K Units), 2016-2021
Table 20. By Application - Global Biologics and Biosimilars Sales (K Units), 2022-2027
Table 21. By Region – Global Biologics and Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Biologics and Biosimilars Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Biologics and Biosimilars Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Biologics and Biosimilars Sales (K Units), 2016-2021
Table 25. By Region - Global Biologics and Biosimilars Sales (K Units), 2022-2027
Table 26. By Country - North America Biologics and Biosimilars Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Biologics and Biosimilars Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Biologics and Biosimilars Sales, (K Units), 2016-2021
Table 29. By Country - North America Biologics and Biosimilars Sales, (K Units), 2022-2027
Table 30. By Country - Europe Biologics and Biosimilars Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Biologics and Biosimilars Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Biologics and Biosimilars Sales, (K Units), 2016-2021
Table 33. By Country - Europe Biologics and Biosimilars Sales, (K Units), 2022-2027
Table 34. By Region - Asia Biologics and Biosimilars Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Biologics and Biosimilars Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Biologics and Biosimilars Sales, (K Units), 2016-2021
Table 37. By Region - Asia Biologics and Biosimilars Sales, (K Units), 2022-2027
Table 38. By Country - South America Biologics and Biosimilars Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Biologics and Biosimilars Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Biologics and Biosimilars Sales, (K Units), 2016-2021
Table 41. By Country - South America Biologics and Biosimilars Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Biologics and Biosimilars Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Biologics and Biosimilars Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Biologics and Biosimilars Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Biologics and Biosimilars Sales, (K Units), 2022-2027
Table 46. Roche Corporate Summary
Table 47. Roche Biologics and Biosimilars Product Offerings
Table 48. Roche Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Amgen Corporate Summary
Table 50. Amgen Biologics and Biosimilars Product Offerings
Table 51. Amgen Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. AbbVie Corporate Summary
Table 53. AbbVie Biologics and Biosimilars Product Offerings
Table 54. AbbVie Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Sanofi-Aventis Corporate Summary
Table 56. Sanofi-Aventis Biologics and Biosimilars Product Offerings
Table 57. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Johnson & Johnson Corporate Summary
Table 59. Johnson & Johnson Biologics and Biosimilars Product Offerings
Table 60. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Biologics and Biosimilars Product Offerings
Table 63. Pfizer Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Novo Nordisk Corporate Summary
Table 65. Novo Nordisk Biologics and Biosimilars Product Offerings
Table 66. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Eli Lilly Corporate Summary
Table 68. Eli Lilly Biologics and Biosimilars Product Offerings
Table 69. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Novartis Corporate Summary
Table 71. Novartis Biologics and Biosimilars Product Offerings
Table 72. Novartis Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Merck Corporate Summary
Table 74. Merck Biologics and Biosimilars Product Offerings
Table 75. Merck Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. 3sbio Corporate Summary
Table 77. 3sbio Biologics and Biosimilars Product Offerings
Table 78. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. Changchun High Tech Corporate Summary
Table 80. Changchun High Tech Biologics and Biosimilars Product Offerings
Table 81. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 82. CP Guojian Corporate Summary
Table 83. CP Guojian Biologics and Biosimilars Product Offerings
Table 84. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 85. Biotech Corporate Summary
Table 86. Biotech Biologics and Biosimilars Product Offerings
Table 87. Biotech Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 88. Gelgen Corporate Summary
Table 89. Gelgen Biologics and Biosimilars Product Offerings
Table 90. Gelgen Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 91. Innovent Corporate Summary
Table 92. Innovent Biologics and Biosimilars Product Offerings
Table 93. Innovent Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 94. Dong Bao Corporate Summary
Table 95. Dong Bao Biologics and Biosimilars Product Offerings
Table 96. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 97. Ganlee Corporate Summary
Table 98. Ganlee Biologics and Biosimilars Product Offerings
Table 99. Ganlee Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 100. United Laboratories Corporate Summary
Table 101. United Laboratories Biologics and Biosimilars Product Offerings
Table 102. United Laboratories Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 103. Biologics and Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 104. Global Biologics and Biosimilars Capacity Market Share of Key Manufacturers, 2019-2021
Table 105. Global Biologics and Biosimilars Production by Region, 2016-2021 (K Units)
Table 106. Global Biologics and Biosimilars Production by Region, 2022-2027 (K Units)
Table 107. Biologics and Biosimilars Market Opportunities & Trends in Global Market
Table 108. Biologics and Biosimilars Market Drivers in Global Market
Table 109. Biologics and Biosimilars Market Restraints in Global Market
Table 110. Biologics and Biosimilars Raw Materials
Table 111. Biologics and Biosimilars Raw Materials Suppliers in Global Market
Table 112. Typical Biologics and Biosimilars Downstream
Table 113. Biologics and Biosimilars Downstream Clients in Global Market
Table 114. Biologics and Biosimilars Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Biologics and Biosimilars Segment by Type
Figure 2. Biologics and Biosimilars Segment by Application
Figure 3. Global Biologics and Biosimilars Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biologics and Biosimilars Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Biologics and Biosimilars Revenue, 2016-2027 (US$, Mn)
Figure 7. Biologics and Biosimilars Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biologics and Biosimilars Revenue in 2020
Figure 9. By Type - Global Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 10. By Type - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 11. By Type - Global Biologics and Biosimilars Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 13. By Application - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 14. By Application - Global Biologics and Biosimilars Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 16. By Region - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 17. By Country - North America Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 18. By Country - North America Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 19. US Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 24. Germany Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 25. France Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 33. China Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 37. India Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 39. By Country - South America Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 40. Brazil Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 44. Turkey Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 48. Global Biologics and Biosimilars Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Biologics and Biosimilars by Region, 2020 VS 2027
Figure 50. Biologics and Biosimilars Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Biologics and Biosimilars Segment by Type
Figure 2. Biologics and Biosimilars Segment by Application
Figure 3. Global Biologics and Biosimilars Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biologics and Biosimilars Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Biologics and Biosimilars Revenue, 2016-2027 (US$, Mn)
Figure 7. Biologics and Biosimilars Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biologics and Biosimilars Revenue in 2020
Figure 9. By Type - Global Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 10. By Type - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 11. By Type - Global Biologics and Biosimilars Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 13. By Application - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 14. By Application - Global Biologics and Biosimilars Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 16. By Region - Global Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 17. By Country - North America Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 18. By Country - North America Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 19. US Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 24. Germany Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 25. France Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 33. China Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 37. India Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 39. By Country - South America Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 40. Brazil Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Biologics and Biosimilars Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Biologics and Biosimilars Sales Market Share, 2016-2027
Figure 44. Turkey Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Biologics and Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 48. Global Biologics and Biosimilars Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Biologics and Biosimilars by Region, 2020 VS 2027
Figure 50. Biologics and Biosimilars Industry Value Chain
Figure 51. Marketing Channels
